March 30, 2017 11:33 AM ET

Healthcare Equipment and Supplies

Company Overview of Akonni Biosystems, Inc.

Company Overview

Akonni Biosystems, Inc., a molecular diagnostics company, develops, manufactures, and markets integrated molecular diagnostic systems for clinical and life science research markets. The company offers TruDiagnosis, a point-of-care molecular testing platform that enables physicians or lab technicians to analyze infectious diseases. Its products include TruTip kits for DNA/RNA extraction and purification; TruArray tests that provide multiplexed molecular diagnostic (MDx) analyses starting from clinical samples, such as blood, saliva, or urine; and MDx instrument platforms, including microarray readers, thermal cyclers, and software. The company’s products are used in the diagnosis of infectiou...

400 Sagner Avenue

Suite 300

Frederick, MD 21701

United States

Founded in 2003





Key Executives for Akonni Biosystems, Inc.

Founder, Chief Executive Officer, President and Director
Vice President of Operations
Director of Engineering
Director of Application Development
Vice President of Regulatory Affairs
Compensation as of Fiscal Year 2016.

Akonni Biosystems, Inc. Key Developments

Akonni Biosystems, Inc. Announces Executive Changes

Akonni Biosystems announced the appointments of key members to its leadership team. Michael Murphy, M.Sc. joined as Vice President, Regulatory Affairs; Sandra Foster, Ph.D. as Director of Quality Assurance and Michael Reinemann, MPH as Director of Business Development. The new additions to Akonni’s leadership team fill critical gaps needed to ensure Akonni’s successful commercialization of its robust product lines. These experienced individuals further strengthen Akonni’s leadership team as the company prepares for its first FDA submission for a pharmacogenomic test on the Akonni TruDiagnosis® system. Prior to joining Akonni, Mr. Murphy served for 7 years as President of Conatus Consulting, a regulatory consulting practice based in Raleigh, NC. Mr. Murphy is a frequent lecturer and author on Pharmacogenomic topics, and currently sits on the editorial review board of the journal, Pharmacogenomics. Sandra Foster brings a unique blend of scientific knowledge and quality experience. Prior to joining Akonni in June of 2016, Mr. Reinemann served in various Commercial Operations roles at Qiagen.

Akonni Biosystems, Inc. Presents at BIO Europe 2016 Conference, Nov-07-2016

Akonni Biosystems, Inc. Presents at BIO Europe 2016 Conference, Nov-07-2016 . Venue: KoelnMesse - Congress Center North, Cologne, Germany.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Private Placement
March 15, 2017
Private Placement
April 30, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Akonni Biosystems, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at